default author photo

Kathryn Rutkowski

International AIDS Vaccine Initiative

SCHOLARLY PAPERS

1

DOWNLOADS

124

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Live-Attenuated M. Tuberculosis Vaccine, MTBVAC, in Adults with or Without M. Tuberculosis Sensitization: A Phase 1b/2a Randomized, Controlled, Double-Blind, Dose-Escalation Trial

Number of pages: 29 Posted: 02 Oct 2023
University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Stellenbosch University, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Biofabri, Biofabri, Biofabri, Biofabri, University of Zaragoza, University of Zaragoza, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative and University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative
Downloads 124 (580,653)

Abstract:

Loading...

tuberculosis, MTBVAC, Vaccine, safety, immunogenicity